Page 107 - 《中国药房》2024年22期
P. 107

措施、健康教育 9 个方面共 37 条证据,具有一定的科学                           质量评价工具[J]. 中国循证心血管医学杂志,2013,5
          性和实用性,可为临床实践提供科学的围术期VTE药物                              (1):3-5.
          预防管理的循证依据,为开展规范的临床实践提供有力                                ZENG X T,HUANG W,TIAN G X. Meta-analysis series
          保证。但本研究仅纳入了中英文文献,且存在RCT样本                               9:quality evaluation tool of meta-analysis[J]. Chin J Evid
                                                                  Based Cardiovasc Med,2013,5(1):3-5.
          量不够大等局限性,今后应进行更大样本量的研究,并
                                                             [10]  MARGULIS A  V,PLADEVALL  M,RIERA-GUARDIA
          在实施方案的过程中,充分考虑患者的意愿和经济状
                                                                  N,et al. Quality assessment of observational studies in a
          况、药物可及性等多方面因素,结合临床情景及医、药、
                                                                  drug-safety  systematic  review,comparison  of  two  tools:
          护人员自身对循证证据的理解,针对性地为患者提供最
                                                                  the  Newcastle-Ottawa  scale  and  the  RTI  item  bank[J].
          适宜的抗凝药物,从而达到最佳的药物预防效果,持续
                                                                  Clin Epidemiol,2014,6:359-368.
          推动临床医疗质量改进。                                        [11]  JING W Z,ZHAO S Y,LIU J,et al. ABO blood groups
          参考文献                                                    and  hepatitis  B  virus  infection:a  systematic  review  and
          [ 1 ]  LAPIDUS  L  J,PONZER  S,PETTERSSON  H,et  al.    meta-analysis[J]. BMJ Open,2020,10(1):e034114.
              Symptomatic  venous  thromboembolism  and  mortality  in   [12]  曾宪涛,包翠萍,曹世义,等 . Meta 分析系列之三:随机
              orthopaedic surgery:an observational study of 45 968 con‐  对照试验的质量评价工具[J]. 中国循证心血管医学杂
              secutive  procedures[J].  BMC  Musculoskelet  Disord,  志,2012,4(3):183-185.
              2013,14:177.                                        ZENG X T,BAO C P,CAO S Y,et al. Meta-analysis se‐
          [ 2 ]  中华医学会骨科学分会. 中国骨科大手术静脉血栓栓塞                        ries  3:quality  evaluation  tool  for  randomized  controlled
              症预防指南[J]. 中华骨科杂志,2016(2):65-71.                     trials[J]. Chin J Evid Based Cardiovasc Med,2012,4(3):
              Chinese Orthopaedic Association. Guidelines for the pre‐  183-185.
              vention of venous thromboembolism in major orthopedic   [13]  王春青,胡雁 . JBI 证据预分级及证据推荐级别系统:
              surgery in China[J]. Chin J Orthop,2016(2):65-71.   2014版[J]. 护士进修杂志,2015,30(11):964-967.
          [ 3 ]  IBRAHIM  M  S,TWAIJ  H,GIEBALY  D  E,et  al.  En‐  WANG  C  Q,HU  Y.  JBI  evidence  pre-classification  and
              hanced recovery in total hip replacement:a clinical review  evidence  rank  system:2014  edition[J].  J  Nurses  Train,
              [J]. Bone Joint J,2013,95-B(12):1587-1594.          2015,30(11):964-967.
          [ 4 ]  National Institute for Health and Care Excellence. Venous   [14]  中华医学会呼吸病学分会肺栓塞与肺血管病学组,中国
              thromboembolism  in  over  16s:reducing  the  risk  of   医师协会呼吸医师分会肺栓塞与肺血管病工作委员会,
              hospital-acquired deep vein thrombosis or pulmonary em‐  全国肺栓塞与肺血管病防治协作组. 肺血栓栓塞症诊治
              bolism[EB/OL]. (2019-08-13) [2023-12-01]. https://www.  与预防指南[J]. 中华医学杂志,2018,98(14):1060-1087.
              nice.org.uk/guidence/ng89.                          Pulmonary  Embolism  and  Pulmonary  Vascular  Disease
          [ 5 ]  韩凤昭,李振知,杨文华. 临床药师参与骨科临床路径中                       Group of the Respiratory Disease Branch of the Chinese
              抗凝治疗的探索与思考[J]. 中南药学,2017,15(8):                     Medical Association,Working  Committee  on  Pulmonary
              1164-1167.                                          Embolism and Pulmonary Vascular Disease of the Respira‐
              HAN F Z,LI Z Z,YANG W H. Role of clinical pharma‐   tory Physicians Branch of the Chinese Medical Doctor
              cists in anticoagulant treatment in orthopedic clinical path‐  Association,National Collaborative Group for Prevention
              ways[J]. Cent South Pharm,2017,15(8):1164-1167.     and  Treatment  of  Pulmonary  Embolism  and  Pulmonary
          [ 6 ]  ZHAI Z G,KAN Q C,LI W M,et al. VTE risk profiles   Vascular  Disease.  Guidelines  on  the  diagnosis,treatment
              and  prophylaxis  in  medical  and  surgical  inpatients:the   and  prevention  of  pulmonary  thromboembolism[J].  Natl
              identification of Chinese hospitalized patients’ risk profile   Med J China,2018,98(14):1060-1087.
              for  venous  thromboembolism (DissolVE-2):a  cross-  [15] 《中国血栓性疾病防治指南》专家委员会. 中国血栓性疾
              sectional study[J]. Chest,2019,155(1):114-122.      病防治指南[J]. 中华医学杂志,2018,98(36):2861-2888.
          [ 7 ]  The AGREE Next Steps Consortium. AGREE Ⅱ transla‐  Expert  Committee  on  Guidelines  for  the  Prevention  and
              tions:Chinese[EB/OL]. (2009-11-12) [2023-12-01]. https://  Treatment  of  Thrombotic  Diseases  in  China.  Guidelines
              www.agreetrust.org/resource-centre/.                for the prevention and treatment of thrombotic diseases in
          [ 8 ]  胡雁,郝玉芳 . 循证护理学[M]. 2 版 . 北京:人民卫生出                China[J]. Natl Med J China,2018,98(36):2861-2888.
              版社,2018:91-93.                                 [16]  全国肺栓塞和深静脉血栓形成防治能力建设项目专家
              HU Y,HAO Y F. Evidence-based nursing[M]. 2nd edition.   委员会,《医院内静脉血栓栓塞症防治质量评价与管理
              Beijing:People’s Medical Publishing House,2018:91-93.  指南(2022版)》编写专家组. 医院内静脉血栓栓塞症防
          [ 9 ]  曾宪涛,黄伟,田国祥. Meta分析系列之九:Meta分析的                   治质量评价与管理指南:2022 版[J]. 中华医学杂志,


          中国药房  2024年第35卷第22期                                              China Pharmacy  2024 Vol. 35  No. 22    · 2805 ·
   102   103   104   105   106   107   108   109   110   111   112